Citius Oncology, Inc. (CTOR) Operating cash flow 2022–2025
Citius Oncology, Inc. (CTOR) annual operating cash flow history from SEC filings — net cash provided by operating activities each fiscal year.
-$5.5MFY2025 · since FY2022: -$47,968 → -$5.5M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -$5.5M | -4446.6% |
| FY2024 | $126,353 | +121.0% |
| FY2023 | -$601,304 | -1153.6% |
| FY2022 | -$47,968 | — |
Source: SEC XBRL filings · For reference only · Not investment advice
More CTOR financial trends
CTOR RevenueCTOR Net incomeCTOR Net marginCTOR Gross profitCTOR Gross marginCTOR Operating incomeCTOR Operating marginCTOR Free cash flowCTOR Capital expendituresCTOR Return on equityCTOR Stock buybacksCTOR Dividends paidCTOR Total assetsCTOR Total liabilitiesCTOR Shareholders’ equityCTOR overview →